Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_3

20%

Ph phase_2

20%

Ph not_applicable

60%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

1(20.0%)

Phase 3Large-scale testing

1(20.0%)

N/ANon-phased studies

3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(3)

Other(1)

Detailed Status

Completed3

Enrolling by invitation1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (20.0%)

Phase 31 (20.0%)

N/A3 (60.0%)

Trials by Status

enrolling_by_invitation120%

completed360%

unknown120%

Recent Activity

0 active trials

Showing 5 of 5

enrolling_by_invitationnot_applicable

Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica

NCT06133530

completedphase_3

Clinical Trials (5)

Showing 5 of 5 trials

NCT06133530Not Applicable

Human Milk Oligosaccharides (HMOs) and Gut Microbiota, Immune System in Antarctica

Enrolling By Invitation

NCT02800161Phase 3

Trehalose as add-on Therapy in Bipolar Depression

Completed

NCT04399265Not Applicable

Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3

Unknown

NCT04505800Not Applicable

Tryptophan Supplementation to Improve Night Shift Workers' Health

Completed

NCT01146535Phase 2

Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment

Completed

All 5 trials loaded

Drug Details

Intervention Type: DIETARY SUPPLEMENT
Total Trials: 5